# A Study of the Efficacy of Prolonged-Release Melatonin Versus Placebo in Diabetic Patients Suffering From Insomnia

> **NCT00869128** · PHASE2 · COMPLETED · sponsor: **Neurim Pharmaceuticals Ltd.** · enrollment: 36 (actual)

## Conditions studied

- Diabetes Mellitus, Type 2
- Insomnia

## Interventions

- **DRUG:** Circadin
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00869128
- **Lead sponsor:** Neurim Pharmaceuticals Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1995-11
- **Primary completion:** 1997-03
- **Final completion:** 1997-03
- **Target enrollment:** 36 (ACTUAL)
- **Last updated:** 2009-05-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00869128

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00869128, "A Study of the Efficacy of Prolonged-Release Melatonin Versus Placebo in Diabetic Patients Suffering From Insomnia". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00869128. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*